Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned ModelCompany AnnouncementGenmab to acquire Merus for USD 97.00 per share in an all-cash transaction ...
Potentially hazardous ready-to-eat food prepared in the food facility and held for more than 24 hours, located in the walk-in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback